A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

ClinicalTrials.gov ID: NCT07061288

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07061288. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Phase 1, Dose-Finding Study to Characterize the Safety, Tolerability, and Pharmacokinetics of a Long-Acting Injectable KarXT Formulation in Participants With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to evaluate the safety, tolerability, and PK of an injectable form of KarXT in participants with schizophrenia

Study identification

NCT ID: NCT07061288
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Bristol-Myers Squibb; Industry
Enrollment: 131 participants

Conditions and interventions

Conditions

Schizophrenia

Interventions

KarXT Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 55 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 3, 2025 (Actual)
Primary completion: Jun 21, 2027 (Estimated)
Completion: Oct 15, 2027 (Estimated)
Last update posted: Sep 2, 2026

2025 – 2027

United States locations

U.S. sites: 8
U.S. states: 6
U.S. cities: 8

Facility	City	State	ZIP	Site status
Collaborative Neuroscience Research, LLC	Los Alamitos	California	90720-3118	Recruiting
Research Centers of America ( Hollywood )	Hollywood	Florida	33024	Recruiting
Innovative Clinical Research, Inc.	Miami Lakes	Florida	33016	Recruiting
Atlanta Center for Medical Research	Atlanta	Georgia	30331	Recruiting
CenExel iResearch, LLC	Decatur	Georgia	30030	Recruiting
Uptown Research Institute	Chicago	Illinois	60640	Recruiting
Hassman Research Institute Marlton Site	Marlton	New Jersey	08053	Recruiting
Community Clinical Research	Austin	Texas	78754	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07061288, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 2, 2026 · Synced Nov 12, 2026